Corpus ID: 55400506

Applications of In Silico Methodologies in Exploring the InhibitoryPotentials of Fisetin on MMP-8 and MMP-13 in Colorectal CancerProgression

@article{Aderibigbe2017ApplicationsOI,
  title={Applications of In Silico Methodologies in Exploring the InhibitoryPotentials of Fisetin on MMP-8 and MMP-13 in Colorectal CancerProgression},
  author={Arowosegbe Michael Aderibigbe and Ogunleye Adewale Joseph and O. EniafeGabriel and O. Idowu and Ehima Victoria Obiajuru and M. D. Samuel and Ogungbe Bimpe and Kanmodi Rahmon Ilesanmi and Ogunmola Oluwafemi Jude},
  journal={International Journal of Drug Development and Research},
  year={2017},
  volume={9}
}
Matrix metalloproteinases, MMP-8 and MMP-13, play crucial roles in the prognosis of colorectal cancer (CRC). Although some literatures consider MMP-8 as a double-edged sword, based on its ambiguous effects in tumouriogenesis. A conglomeration of evidence has revealed that MMP-8 and MMP-13 are requisite in the degradation and remodelling of components of the extracellular matrix in colorectal cancer progression. Therefore, it is apposite to timely inhibit these Zn-dependent endopeptidases… Expand
Applications of In Silico Methodologies in Exploring the InhibitoryPotentials of Fisetin on MMP-8 and MMP-13 in Colorectal CancerProgression
TLDR
Findings from this study corroborate other findings, indicating that fisetin is probable potent anticancer drug and it can significantly palliate CRC invasion and metastasis. Expand

References

SHOWING 1-10 OF 58 REFERENCES
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer
TLDR
Current strategies for development of inhibitors with therapeutic potential that are capable of selectively targeting the MMPs most responsible for tumor promotion are discussed, with special consideration of the potential of biologics including antibodies and engineered proteins based on the TIMP scaffold. Expand
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
TLDR
This minireview critically evaluates the role of MMPs in relation to cancer progression, and highlights the challenges, as well as future prospects, for the design, development and efficacy of M MPIs. Expand
Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas
TLDR
The role of MMPs in cancer, clinical trials for MMP inhibitors, and novel approaches to targeting MMP's in cancer are highlighted. Expand
Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
TLDR
Findings on the tissue and blood expression of MMPs, their function, regulation and prognostic implication in human prostate cancer are summarized, with a focus on MMP-2, -7, -9, MT1-MMP and tissue inhibitor of metalloproteinase 1 (TIMP-1). Expand
Role of matrix metalloproteinases (MMPs) in colorectal cancer
TLDR
Several orally active, low molecular weight inhibitors of MMPs (MMPIs) have been developed and have been effective in controlling cancer progression in animals, but have failed to prolong survival in phase III clinical trials in patients with advanced cancer. Expand
The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal Cancer
TLDR
The pharmacological targeting of CRC by the development of a new generation of selective inhibitors of M MPs, that is highly specific for certain MMPs, is a promising and challenging area for the future. Expand
Is there new hope for therapeutic matrix metalloproteinase inhibition?
TLDR
The recent advances made in understanding the role of MMPs in inflammatory diseases and the therapeutic potential of M Parliamentary metalloproteinases inhibition in those conditions are discussed. Expand
Antimetastatic potential of fisetin involves inactivation of the PI3K/Akt and JNK signaling pathways with downregulation of MMP-2/9 expressions in prostate cancer PC-3 cells
TLDR
Results showed fisetin could inhibit the metastatic ability of PC-3 by reducing M MP-2 and MMP-9 expressions through suppressing phosphoinositide 3-kinase/Akt (PI3K/ akt) and JNK signaling pathways. Expand
The role of gelatinases in colorectal cancer progression and metastasis.
TLDR
It is concluded that the use of MMP inhibitors to treat cancer should be considered carefully because of the multifunctionality of gelatinases, it is unpredictable at what stage of cancer development and in which processes gelatinase activity is involved. Expand
Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis
The purpose of this review is to highlight the recent mechanistic developments elucidating the role of matrix metalloproteinases (MMPs) in tumour invasion and metastasis. The ability of tumour cellsExpand
...
1
2
3
4
5
...